XML 42 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives (Tables)
9 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The fair value of derivative instruments on a gross basis was as follows on the dates indicated (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value of Derivative Instruments Designated as Hedging Instruments

 

Balance Sheet Location

    

September 30, 2021

    

December 31, 2020

Assets

 

  

 

​

  

 

​

  

Foreign currency forward contracts

 

Prepaid expenses and other assets

​

$

1,237

​

$

1,777

Foreign currency forward contracts

 

Other assets (long-term)

​

 

236

​

 

424

​

​

​

​

​

​

​

​

​

(Liabilities)

 

  

​

 

  

​

 

  

Interest rate swaps

​

Accrued expenses

​

​

—

​

​

(896)

Interest rate swaps

​

Other long-term obligations

​

​

(2,540)

​

​

(3,462)

Foreign currency forward contracts

 

Accrued expenses

​

 

(1,779)

​

 

(5,281)

Foreign currency forward contracts

 

Other long-term obligations

​

 

(260)

​

 

(866)

​

​

​

​

​

​

​

​

​

Fair Value of Derivative Instruments Not Designated as Hedging Instruments

 

Balance Sheet Location

    

September 30, 2021

    

December 31, 2020

Assets

 

  

​

 

  

​

 

  

Foreign currency forward contracts

 

Prepaid expenses and other assets

​

$

966

​

$

877

​

​

​

​

​

​

​

​

​

(Liabilities)

 

  

​

 

  

​

 

  

Foreign currency forward contracts

 

Accrued expenses

​

 

(1,054)

​

 

(2,120)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income (“OCI”), accumulated other comprehensive income (“AOCI”), and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Amount of Gain/(Loss)

​

​

​

Consolidated Statements

​

Amount of Gain/(Loss)

​

​

Recognized in OCI

​

​

​

of Income (Loss)

​

Reclassified from AOCI

​

​

Three Months Ended September 30, 

 

​

  

Three Months Ended September 30, 

​

Three Months Ended September 30, 

Derivative instrument

    

2021

 

2020

    

Location in statements of income

    

2021

  

  

2020

  

2021

  

  

2020

Interest rate swaps

​

$

(18)

​

$

(30)

​

Interest expense

​

$

(1,233)

​

$

(2,197)

​

$

(319)

​

$

(425)

Foreign currency forward contracts

​

 

33

​

 

(1,324)

​

Revenue

​

 

267,021

​

 

243,975

​

 

(1,500)

​

 

157

​

​

​

​

​

​

​

​

Cost of sales

​

 

(146,527)

​

 

(141,961)

​

 

312

​

 

(494)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Amount of Gain/(Loss)

​

​

​

Consolidated Statements

​

Amount of Gain/(Loss)

​

​

Recognized in OCI

​

​

​

of Income (Loss)

​

Reclassified from AOCI

​

​

Nine Months Ended September 30, 

 

​

​

Nine Months Ended September 30, 

​

Nine Months Ended September 30, 

Derivative instrument

    

2021

 

2020

    

Location in statements of income

    

2021

 

​

2020

  

2021

 

 

2020

Interest rate swaps

​

$

619

​

$

(6,256)

​

Interest expense

​

$

(4,156)

​

$

(8,056)

​

$

(1,198)

​

$

(439)

Foreign currency forward contracts

​

 

(83)

​

 

(2,596)

​

Revenue

​

 

796,259

​

 

705,871

​

 

(4,674)

​

 

666

​

​

​

​

Cost of sales

​

 

(439,732)

​

 

(415,857)

​

 

966

​

 

(1,204)

Derivative Instruments, Gain (Loss)

The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the periods presented (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Three Months Ended September 30, 

    

Nine Months Ended September 30, 

Derivative Instrument

 

Location in statements of income (loss)

 

2021

 

2020

 

2021

 

2020

Foreign currency forward contracts

 

Other income (expense)

​

$

39

​

$

(1,294)

​

$

(709)

​

$

1,051